{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:46:22Z","timestamp":1787031982145,"version":"build-2736575974"},"reference-count":36,"publisher":"Georg Thieme Verlag KG","issue":"S 01","license":[{"start":{"date-parts":[[2017,12,28]],"date-time":"2017-12-28T00:00:00Z","timestamp":1514419200000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hamostaseologie"],"published-print":{"date-parts":[[2017,12]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>Ultralarge multimers (ULM) of VWF are considered to be the most active with respect to binding to platelets and to subendothelial structures and therefore are of critical importance for the function of VWF in stabilizing the primary hemostatic plug. In contrast to plasma-derived FVIII-VWF concentrates, human rVWF obtained from mammalian cell culture retains the full-spectrum of intact multimers, including ULM, as physiologically formed in the Golgi apparatus and stored in platelet \u03b1-granules and endothelial cell Weibel\u2013Palade bodies. In the course of physico and biochemical, functional and animal studies, rVWF exhibited superiority in structure and function compared to pdVWF. These effects seemed to correlate with the multimer size and therefore might be attributed to the presence of ULM in rVWF preparations. The pharmacokinetic (PK), safety and efficacy characteristics seen in preclinical studies were further demonstrated in clinical trials.<\/jats:p>","DOI":"10.5482\/hamo-17-04-0018","type":"journal-article","created":{"date-parts":[[2018,3,20]],"date-time":"2018-03-20T04:33:12Z","timestamp":1521520392000},"page":"S15-S25","source":"Crossref","is-referenced-by-count":9,"special_numbering":"S","title":["The role of ultralarge multimers in recombinant human von Willebrand factor \u2013 a review of physico-and biochemical studies and findings in in vivo models and in humans with von Willebrand disease"],"prefix":"10.5482","volume":"37","author":[{"given":"Peter L","family":"Turecek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Spannagl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Kragh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guenter","family":"Allmaier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marietta","family":"Turecek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Schrenk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert","family":"Gritsch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ortrun","family":"Obermann-Slupetzky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce M","family":"Ewenstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard A","family":"Valentino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2017,12,28]]},"reference":[{"issue":"S 01","key":"ref1","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.thromres.2007.03.011","article-title":"The role of von Willebrand factor in thrombus formation","volume":"120","author":"ZM Ruggeri","year":"2007","journal-title":"Thromb Res"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1182\/blood.V88.5.1525.1525","article-title":"Platelets and shear stress","volume":"88","author":"MH Kroll","year":"1996","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1182\/blood.V92.11.3983","article-title":"The life cycle of coagulation factor VIII in view of its structure and function","volume":"92","author":"PJ Lenting","year":"1998","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1172\/JCI108788","article-title":"Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand\u2019s disease","volume":"60","author":"HJ Weiss","year":"1977","journal-title":"J Clin Invest"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1160\/TH07-10-0629","article-title":"Clearance of von Willebrand factor","volume":"99","author":"CV Denis","year":"2008","journal-title":"Thromb Haemost"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1055\/s-0030-1255445","article-title":"Structure and function of a recombinant von Willebrand factor drug candidate","volume":"36","author":"PL Turecek","year":"2010","journal-title":"Semin Thromb Hemost"},{"issue":"S 02","key":"ref7","first-page":"s3","article-title":"Role of von Willebrand factor in the haemostasis","volume":"09","author":"F Peyvandi","year":"2011","journal-title":"Blood Transfus"},{"issue":"S 01","key":"ref8","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1538-7836.2009.03375.x","article-title":"von Willebrand factor assembly and secretion","volume":"07","author":"JE Sadler","year":"2009","journal-title":"J Thromb Haemost"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"14.","DOI":"10.1186\/1477-9560-5-14","article-title":"Relationship between ABO blood group and von Willebrand factor levels: from biology to clinical implications","volume":"05","author":"M Franchini","year":"2007","journal-title":"Thromb J"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1182\/blood-2013-11-538173","article-title":"Control of VWF A2 domain stability and ADAMTS13 access to the scissile bond of full-length VWF","volume":"123","author":"CJ Lynch","year":"2014","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/ajh.23527","article-title":"ADAMTS13 content in plasma-derived factor VIII\/von Willebrand factor concentrates","volume":"88","author":"F Peyvandi","year":"2013","journal-title":"Am J Hematol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/jth.12867","article-title":"No evidence for a direct effect of von Willebrand factor\u2019s ABH blood group antigens on von Willebrand factor clearance","volume":"13","author":"DJ Groeneveld","year":"2015","journal-title":"J Thromb Haemost"},{"key":"ref13","first-page":"S32","article-title":"Development of a plasma-and albumin-free recombinant von Willebrand factor","volume":"29 su01","author":"PL Turecek","year":"2009","journal-title":"Hamostaseologie"},{"issue":"02","key":"ref15","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2516.2009.02181.x","article-title":"Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia","volume":"16","author":"A Peden","year":"2010","journal-title":"Haemophilia"},{"issue":"04","key":"ref16","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.thromres.2007.05.015","article-title":"What a polyclonal antibody sees in von Willebrand factor","volume":"121","author":"FL Tan","year":"2008","journal-title":"Thromb Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s00216-013-7563-0","article-title":"Visualization of a protein-protein interaction at single molecule level by atomic force microscopy. Ana","volume":"406","author":"K Bonazza","year":"2014","journal-title":"Bioanal Chem"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"044117.","DOI":"10.1063\/1.5000503","article-title":"A bio-inspired method for direct measurement of local wall shear rates with micrometer localization using the multimeric protein von Willebrand factor as sensor molecule","volume":"11","author":"K Bonazza","year":"2017","journal-title":"Biomicrofluidics"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1160\/TH10-02-0081","article-title":"Comparison of plasma-derived and recombinant von Willebrand factor by atomic force microscopy","volume":"104","author":"BK Seyfried","year":"2010","journal-title":"Thromb Haemost"},{"key":"ref20","first-page":"319","article-title":"Role of fluid shear stress in regulating VWF structure, function and related blood disorders","volume":"52","author":"S Gogia","year":"2015","journal-title":"Biorheology"},{"issue":"05","key":"ref21","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1182\/blood-2013-01-479527","article-title":"Pharmacokinetics and safety of a novel recombinant human von Willebrand factor manufactured with a plasma-free method: a prospective clinical trial","volume":"122","author":"PM Mannucci","year":"2013","journal-title":"Blood"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1055\/s-0030-1255446","article-title":"Preclinical testing of human recombinant von Willebrand factor: ADAMTS13 cleavage capacity in animals as criterion for species suitability","volume":"36","author":"EM Muchitsch","year":"2010","journal-title":"Semin Thromb Hemost"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"6051","DOI":"10.1007\/s00216-015-8778-z","article-title":"Ca(2+) concentration-dependent conformational change of FVIII B-domain observed by atomic force microscopy","volume":"407","author":"K Bonazza","year":"2015","journal-title":"Anal Bioanal Chem"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.thromres.2014.03.024","article-title":"High shear dependent von Willebrand factor self-assembly fostered by platelet interaction and controlled by ADAMTS13","volume":"133","author":"T Kragh","year":"2014","journal-title":"Thromb Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1055\/s-2002-27823","article-title":"Recombinant von Willebrand factor-insight into structure and function through infusion studies in animals with severe von Willebrand disease","volume":"28","author":"HP Schwarz","year":"2002","journal-title":"Semin Thromb Hemost"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/j.1538-7836.2009.03453.x","article-title":"Species-dependent variability of ADAMTS13-mediated proteolysis of human recombinant von Willebrand factor","volume":"07","author":"K Varadi","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"16","key":"ref27","doi-asserted-by":"crossref","first-page":"9524","DOI":"10.1073\/pnas.95.16.9524","article-title":"A mouse model of severe von Willebrand disease: defects in hemostasis and thrombosis","volume":"95","author":"C Denis","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1182\/blood.V90.9.3555","article-title":"In vivo characterization of recombinant von Willebrand factor in dogs with von Willebrand disease","volume":"90","author":"PL Turecek","year":"1997","journal-title":"Blood"},{"issue":"S 03","key":"ref29","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1365-2516.1998.0040s3053.x","article-title":"Evaluation of recombinant von Willebrand factor in a canine model of von Willebrand disease","volume":"04","author":"HP Schwarz","year":"1998","journal-title":"Haemophilia"},{"issue":"03","key":"ref30","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0014-5793(95)01218-4","article-title":"Structural analysis of recombinant von Willebrand factor produced at industrial scale fermentation of transformed CHO cells co-expressing recombinant furin","volume":"375","author":"BE Fischer","year":"1995","journal-title":"FEBS Lett"},{"issue":"11","key":"ref31","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1182\/blood.V85.11.3150.bloodjournal85113150","article-title":"The affinity and stoichiometry of binding of human factor VIII to von Willebrand factor","volume":"85","author":"AJ Vlot","year":"1995","journal-title":"Blood"},{"issue":"18","key":"ref32","doi-asserted-by":"crossref","first-page":"8443","DOI":"10.1016\/S0021-9258(18)47430-3","article-title":"A major factor VIII binding domain resides within the amino-terminal 272 amino acid residues of von Willebrand factor","volume":"262","author":"PA Foster","year":"1987","journal-title":"J Biol Chem"},{"issue":"01","key":"ref33","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0049-3848(96)00161-2","article-title":"Effect of multimerization of human and recombinant von Willebrand factor on platelet aggregation, binding to collagen and binding of coagulation factor VIII","volume":"84","author":"BE Fischer","year":"1996","journal-title":"Thromb Res"},{"issue":"19","key":"ref34","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1182\/blood-2014-09-603241","article-title":"von Willebrand factor propeptide and the phenotypic classification of von Willebrand disease","volume":"125","author":"YV Sanders","year":"2015","journal-title":"Blood"},{"issue":"04","key":"ref35","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1177\/1076029606293422","article-title":"Classification and characterization of hereditary types 2A,2B, 2C, 2D, 2E, 2M, 2N, and 2U (unclassifiable) von Willebrand disease","volume":"12","author":"JJ Michiels","year":"2006","journal-title":"Clin Appl Thromb Hemost"},{"issue":"02","key":"ref36","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1182\/blood.V92.2.529","article-title":"Binding of factor VIII to von willebrand factor is enabled by cleavage of the von Willebrand factor propeptide and enhanced by formation of disulfide-linked multimers","volume":"92","author":"AV Bendetowicz","year":"1998","journal-title":"Blood"},{"issue":"20","key":"ref37","doi-asserted-by":"crossref","first-page":"10299","DOI":"10.1021\/acs.analchem.5b02078","article-title":"Shear-dependant interactions of von Willebrand Factor with Factor VIII and protease ADAMTS 13 demonstrated at a single molecule level by atomic force microscopy","volume":"87","author":"K Bonazza","year":"2015","journal-title":"Anal Chem"}],"container-title":["H\u00e4mostaseologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.5482\/HAMO-17-04-0018.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T22:59:06Z","timestamp":1776812346000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.5482\/HAMO-17-04-0018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":36,"journal-issue":{"issue":"S 01","published-online":{"date-parts":[[2017,12,28]]},"published-print":{"date-parts":[[2017,12]]}},"URL":"https:\/\/doi.org\/10.5482\/hamo-17-04-0018","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0720-9355","2567-5761"],"issn-type":[{"value":"0720-9355","type":"print"},{"value":"2567-5761","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]}}}